Showing results (61-70 of 295) with videos related to

Sort By:
Pageof 30
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 21, 2025
Radiotherapy of breast cancer: 2025 updateYoussef Ghannam, Romuald Le Scodan, Sofia Rivera, et al.
Critical Reviews in Oncology/Hematology|August 19, 2007
Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: focus on clinical trials and perspectivesJoseph Gligorov, David Azria, Moise Namer, et al.
Radiation Oncology (London, England)|November 10, 2010
Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndromeSteve Heymann, Suzette Delaloge, Arslane Rahal, et al.
Clinical Advances in Hematology & Oncology : H&O|April 20, 2013
SHARE: a French multicenter phase III trial comparing accelerated partial irradiation versus standard or hypofractionated whole breast irradiation in breast cancer patients at low risk of local recurrenceYazid Belkacemi, Céline Bourgier, Andrew Kramar, et al.
Bulletin Du Cancer|December 14, 2011
[Radiosensitivity assays of normal tissues]Jérôme Lacombe, Jérôme Solassol, Jean-Pierre Pouget, et al.
BMC Cancer|April 30, 2011
Growth of breast cancer recurrences assessed by consecutive MRIIngrid Millet, Emmanuelle Bouic-Pages, Denis Hoa, et al.
Swiss Medical Weekly|January 22, 2005
External radiotherapy and anaemia treatment: state of the artMahmut Ozsahin, David Azria, Karl Beer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 4, 2025
Development of Multiparametric Prognostic Models for Stereotactic Magnetic Resonance Guided Radiation Therapy of Pancreatic CancersMorgan Michalet, Gladis Valenzuela, Stéphanie Nougaret, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2012
Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendationsFlorence Huguet, Karyn A Goodman, David Azria, et al.
Onkologie|June 19, 2013
Clinical benefit for patients with non-small cell lung cancer enrolled in phase I trialsAntonin Levy, Carlos Gomez-Roca, Christophe Massard, et al.
Pageof 30